Cardiology centres worldwide experience an almost exponential rise in the number of in-hospital follow-ups of patients with implantable devices or heart failure (HF).This not only strains the available personnel resources, it also means a rapidly increasing cost to healthcare payers, especially in fee-for-service reimbursement situations.
The global prevalence of Type 2 diabetes mellitus is rapidly accelerating towards a disastrous impact in just two decades.
CS-200: SCHILLER´s complete Diagnostic Solution has been redesigned, offering now even more added value. Discreet but important external modifications encompass a large, swivel-mounted 19`` monitor, as well as an ergonomic design. A new, simplified user-interface as well as various new holders and mounting kits for external devices such as gel bottles, bar code scanners, spirometry sensors and…
As Professor Valentin Fuster pointed out this year, the Centro Nacional de Investigaciones Cardiovasculares (CNIC) is now a splendid reality thanks to the support of the Ministerio de Ciencia y Tecnología and the Instituto de Salud Carlos III institutions on which, now and for the future, it depends. Along with that public sector backing, CNIC will also receive civil support from the ProCNIC…
After two years of intensive work the results from the German pilot phase of the EuroCMR Register are due to be published in the forthcoming issue of the Journal of the American College of Cardiology*, and also presented and discussed in detail at this year's ECR in Barcelona.
Measuring left ventricle ejection fraction (LVEF) is the gold standard for determining the risk of cardiac death or sudden cardiac death after a myocardial infarction (MI). If LVEF is below 30%, a cardioverter-defibrillator is implanted to avoid such an event.
Previewing technologies that may be in use in about a decade, Philips Healthcare recently introduced us to researchers who discussed their many current and ongoing projects.
Since 2007, when a special public information website was set up by the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) intended to help heart failure (HF) patients, their families and carers by offering a broad range of information, reassurance and support, www.heartfailurematters.org has gained even greater international presence and use in the last 18 months, Mark…
Charité-Wissenschaftler beschreiben die Rolle des Proteins CTGF Wissenschaftler der Charité - Universitätsmedizin Berlin und des Max-Delbrück Centrums für molekulare Medizin (MDC) in Berlin Buch haben die Funktion des Proteins Connective Tissue Growth Factor (CTGF) im Herzen aufgeklärt.
The latest statistics regarding the use of pacemakers and implantable cardiac devices in Europe was presented at EUROPACE 2009, the meeting of the European Heart Rhythm Association (EHRA)1 which takes place in Berlin, Germany from 21 to 24 June. The data show that there is a disparate coverage of diseases and treatments within the EU and the European Society of Cardiology member countries outside…
The use of phone and internet between patients and healthcare providers is an effective way to reduce risk factors for coronary heart disease and the risk of further events after a heart attack, according to new research published in June issue of the European Journal of Cardiovascular Prevention & Rehabilitation.
Testing people for heart disease might be just a finger prick away thanks to a new credit card-sized device created by a team of researchers from Harvard and Northeastern universities in Boston.
Non-smokers live longer and have less cardiovascular disease than those who smoke, according to a 30-year follow-up study of 54,000 men and women in Norway. Smoking, say the investigators, is “strongly” related to cardiovascular morbidity and mortality from various causes.
Echocardiography is the work horse of non-invasive cardiovascular diagnostics. Has this developed?
During KIMES, Karoline Laarmann (European Hospital) met with Joong-Ho Lee, Senior Executive Vice President of the ultrasound systems manufacturer MEDISON, the Korean firm that entered the ultrasound market in the 1980s and quickly established a global reputation for innovative developments (e.g. the firm produced the first commercial real-time 3-D ultrasound scanner).
Agfa HealthCare has released the latest version of its IMPAX HeartStation, a comprehensive management system for electrocardiograms (ECGs). Built on standards-based architecture, the system supports most existing and new ECG devices, integrating easily with the legacy hospital and clinic IT infrastructure and ECG workflow, Agfa reports.
EuroPCR 2009 is focused on minimally invasive cardiac surgery, but narrowing the broad field of cardiology does not make this conference any less complex.
A cocktail of proteins that triggers the production of new heart muscle cells has been discovered by Benoit G Bruneau and Jun Kakeuchi at the Gladstone Institute of Cardiovascular Disease, in San Francisco.
Results of five clinical studies evaluating the predictive value of VENDYS, a new FDA-approved cardiovascular test, were presented at the 2009 Annual Scientific Sessions of the American College of Cardiology in Florida.
In April, the 75th annual congress of the German Cardiac Society (DGK) was considered a great success, drawing in some 7,900 specialists.
Last year a special cardiac surgery department was opened in the Filatov Children's Hospital in Moscow. Until then, the only one in all of Russia was at the Children's Hospital #1, in Saint-Petersburg, where cardiac surgeon Vadim Lubomudrov has led the field in this delicate work.
Healthcare services often do not reach the target groups because socio-cultural preferences and values of patients and their relatives are not properly considered.
Genetic differences can explain why some patients undergoing heart surgery later experience shock and kidney complications, according to a study by German and Australian researchers. The results indicate that performing a genetic test on patients before they have surgery can help guide treatment after they leave the operating room.
Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced the first enrollment in the ACCESS-Europe study, a post-market observational study of the MitraClip therapy in Europe. The system is the first commercially available treatment option for non-surgical mitral valve repair for patients suffering from the effects of functional and…
